Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 126

1.

Knockdown of Lmo7 inhibits chick myogenesis.

Possidonio AC, Soares CP, Fontenelle M, Morris ER, Mouly V, Costa ML, Mermelstein C.

FEBS Lett. 2016 Jan 20. doi: 10.1002/1873-3468.12067. [Epub ahead of print]

PMID:
26786059
2.

Selection-free gene repair after adenoviral vector transduction of designer nucleases: rescue of dystrophin synthesis in DMD muscle cell populations.

Maggio I, Stefanucci L, Janssen JM, Liu J, Chen X, Mouly V, Gonçalves MA.

Nucleic Acids Res. 2016 Jan 13. pii: gkv1540. [Epub ahead of print]

3.

Spell Checking Nature: Versatility of CRISPR/Cas9 for Developing Treatments for Inherited Disorders.

Wojtal D, Kemaladewi DU, Malam Z, Abdullah S, Wong TW, Hyatt E, Baghestani Z, Pereira S, Stavropoulos J, Mouly V, Mamchaoui K, Muntoni F, Voit T, Gonorazky HD, Dowling JJ, Wilson MD, Mendoza-Londono R, Ivakine EA, Cohn RD.

Am J Hum Genet. 2016 Jan 7;98(1):90-101. doi: 10.1016/j.ajhg.2015.11.012. Epub 2015 Dec 10.

PMID:
26686765
4.

CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy.

Pinto-Mariz F, Rodrigues Carvalho L, Prufer De Queiroz Campos Araujo A, De Mello W, Gonçalves Ribeiro M, Cunha Mdo C, Cabello PH, Riederer I, Negroni E, Desguerre I, Veras M, Yada E, Allenbach Y, Benveniste O, Voit T, Mouly V, Silva-Barbosa SD, Butler-Browne G, Savino W.

Skelet Muscle. 2015 Dec 10;5:45. doi: 10.1186/s13395-015-0066-2. eCollection 2015.

5.

Cellular Therapies for Muscular Dystrophies: Frustrations and Clinical Successes.

Negroni E, Bigot A, Butler-Browne GS, Trollet C, Mouly V.

Hum Gene Ther. 2016 Jan 25. [Epub ahead of print]

PMID:
26652770
6.

Post-transcriptional modulation of interleukin 8 by CNOT6L regulates skeletal muscle differentiation.

Polesskaya A, Pinna G, Sassi Y, Vandamme M, Bigot A, Mouly V, Morozova N, Harel-Bellan A, Degerny C.

Biochim Biophys Acta. 2016 Feb;1863(2):263-70. doi: 10.1016/j.bbamcr.2015.11.018. Epub 2015 Dec 1.

PMID:
26608607
7.

Age-Associated Methylation Suppresses SPRY1, Leading to a Failure of Re-quiescence and Loss of the Reserve Stem Cell Pool in Elderly Muscle.

Bigot A, Duddy WJ, Ouandaogo ZG, Negroni E, Mariot V, Ghimbovschi S, Harmon B, Wielgosik A, Loiseau C, Devaney J, Dumonceaux J, Butler-Browne G, Mouly V, Duguez S.

Cell Rep. 2015 Nov 10;13(6):1172-82. doi: 10.1016/j.celrep.2015.09.067. Epub 2015 Oct 29.

8.

Laminin therapy for the promotion of muscle regeneration.

Riederer I, Bonomo AC, Mouly V, Savino W.

FEBS Lett. 2015 Nov 14;589(22):3449-53. doi: 10.1016/j.febslet.2015.10.004. Epub 2015 Oct 10. Review.

PMID:
26459029
9.

Engineering human 3D micromuscles with co-culture of fibroblasts and myoblasts.

Kalman B, Monge C, Bigot A, Mouly V, Picart C, Boudou T.

Comput Methods Biomech Biomed Engin. 2015;18 Suppl 1:1960-1. doi: 10.1080/10255842.2015.1069557. Epub 2015 Aug 21. No abstract available.

PMID:
26296042
10.

β-Arrestin scaffolds and signaling elements essential for the obestatin/GPR39 system that determine the myogenic program in human myoblast cells.

Santos-Zas I, Gurriarán-Rodríguez U, Cid-Díaz T, Figueroa G, González-Sánchez J, Bouzo-Lorenzo M, Mosteiro CS, Señarís J, Casanueva FF, Casabiell X, Gallego R, Pazos Y, Mouly V, Camiña JP.

Cell Mol Life Sci. 2016 Feb;73(3):617-35. doi: 10.1007/s00018-015-1994-z. Epub 2015 Jul 27.

PMID:
26211463
11.

Correlation between low FAT1 expression and early affected muscle in facioscapulohumeral muscular dystrophy.

Mariot V, Roche S, Hourdé C, Portilho D, Sacconi S, Puppo F, Duguez S, Rameau P, Caruso N, Delezoide AL, Desnuelle C, Bessières B, Collardeau S, Feasson L, Maisonobe T, Magdinier F, Helmbacher F, Butler-Browne G, Mouly V, Dumonceaux J.

Ann Neurol. 2015 Sep;78(3):387-400. doi: 10.1002/ana.24446. Epub 2015 Jul 3.

PMID:
26018399
12.

Mitochondrial dysfunction reveals the role of mRNA poly(A) tail regulation in oculopharyngeal muscular dystrophy pathogenesis.

Chartier A, Klein P, Pierson S, Barbezier N, Gidaro T, Casas F, Carberry S, Dowling P, Maynadier L, Bellec M, Oloko M, Jardel C, Moritz B, Dickson G, Mouly V, Ohlendieck K, Butler-Browne G, Trollet C, Simonelig M.

PLoS Genet. 2015 Mar 27;11(3):e1005092. doi: 10.1371/journal.pgen.1005092. eCollection 2015 Mar.

13.

In silico screening based on predictive algorithms as a design tool for exon skipping oligonucleotides in Duchenne muscular dystrophy.

Echigoya Y, Mouly V, Garcia L, Yokota T, Duddy W.

PLoS One. 2015 Mar 27;10(3):e0120058. doi: 10.1371/journal.pone.0120058. eCollection 2015.

14.

Cannabinoid receptor 1 and acute resistance exercise--In vivo and in vitro studies in human skeletal muscle.

Pekkala S, Wiklund P, Hulmi JJ, Pöllänen E, Marjomäki V, Munukka E, Pierre P, Mouly V, Mero A, Alén M, Cheng S.

Peptides. 2015 May;67:55-63. doi: 10.1016/j.peptides.2015.03.007. Epub 2015 Mar 18.

PMID:
25796352
15.

miRNA expression in control and FSHD fetal human muscle biopsies.

Portilho DM, Alves MR, Kratassiouk G, Roche S, Magdinier F, de Santana EC, Polesskaya A, Harel-Bellan A, Mouly V, Savino W, Butler-Browne G, Dumonceaux J.

PLoS One. 2015 Feb 18;10(2):e0116853. doi: 10.1371/journal.pone.0116853. eCollection 2015.

16.

FUBP1: a new protagonist in splicing regulation of the DMD gene.

Miro J, Laaref AM, Rofidal V, Lagrafeuille R, Hem S, Thorel D, Méchin D, Mamchaoui K, Mouly V, Claustres M, Tuffery-Giraud S.

Nucleic Acids Res. 2015 Feb 27;43(4):2378-89. doi: 10.1093/nar/gkv086. Epub 2015 Feb 6.

17.

Intramuscular sex steroid hormones are associated with skeletal muscle strength and power in women with different hormonal status.

Pöllänen E, Kangas R, Horttanainen M, Niskala P, Kaprio J, Butler-Browne G, Mouly V, Sipilä S, Kovanen V.

Aging Cell. 2015 Apr;14(2):236-48. doi: 10.1111/acel.12309. Epub 2015 Jan 20.

18.

IL-6 and Akt are involved in muscular pathogenesis in myasthenia gravis.

Maurer M, Bougoin S, Feferman T, Frenkian M, Bismuth J, Mouly V, Clairac G, Tzartos S, Fadel E, Eymard B, Fuchs S, Souroujon MC, Berrih-Aknin S.

Acta Neuropathol Commun. 2015 Jan 15;3:1. doi: 10.1186/s40478-014-0179-6.

19.

Invited review: Stem cells and muscle diseases: advances in cell therapy strategies.

Negroni E, Gidaro T, Bigot A, Butler-Browne GS, Mouly V, Trollet C.

Neuropathol Appl Neurobiol. 2015 Apr;41(3):270-87. doi: 10.1111/nan.12198. Review.

PMID:
25405809
20.

Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy.

Barthélémy I, Pinto-Mariz F, Yada E, Desquilbet L, Savino W, Silva-Barbosa SD, Faussat AM, Mouly V, Voit T, Blot S, Butler-Browne G.

Dis Model Mech. 2014 Nov;7(11):1253-61. doi: 10.1242/dmm.016014. Epub 2014 Sep 26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk